Dataset Information

Growth differentiation factor-15 and the risk of cardiovascular diseases and all-cause mortality: A meta-analysis of prospective studies.

ABSTRACT:

Background and aim

Previous studies have documented that the association between growth differentiation factor-15 (GDF-15) the risk of patients with cardiovascular diseases (CVDs). In this meta-analysis, our main objective is to explore the associations between GDF-15 and the risk of CVD or all-cause mortality.

Methods

PubMed and ISI Web of Science (up to January 2018) electronic databases were browsed for eligible studies. The studies provided relevant data depicted as hazard ratio (HR) with 95% confidence interval (CI), with regard to the association between GDF-15 levels and subsequent risk of CVDs or all-cause mortality. A random-effect model was applied to pool the HR and 95% CI.

Results

Thirty-one prospective studies met the eligibility criteria involving 53?706 subjects with 7020 adverse outcome events. It was concluded that GDF-15 levels were associated with an incremental risk of CVDs or all-cause mortality. Highest GDF-15 category was associated with greater risk of cardiovascular mortality (HR, 2.66; 95% CI, 1.69-3.63), all-cause mortality (HR, 2.52; 95% CI, 2.06-2.97), and complex adverse outcome (HR, 1.81; 95% CI, 1.42-2.21). As each log-unit increment in GDF-15 concentration, the corresponding risk of adverse events also escalated, cardiovascular mortality (HR, 2.11; 95% CI, 1.57-2.66), all-cause mortality (HR, 2.70; 95% CI, 2.29-3.12), and complex adverse outcome (HR, 1.96; 95% CI, 1.64-2.29).

Conclusions

Judging from the results of the data analysis, GDF-15 levels may increase the risk of CVDs or all-cause mortality.

SUBMITTER: Xie S

PROVIDER: S-EPMC6523003 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Growth differentiation factor-15 and the risk of cardiovascular diseases and all-cause mortality: A meta-analysis of prospective studies.

Xie Shanhui S Lu Liping L Liu Liwei L

Clinical cardiology 20190326 5

<h4>Background and aim</h4>Previous studies have documented that the association between growth differentiation factor-15 (GDF-15) the risk of patients with cardiovascular diseases (CVDs). In this meta-analysis, our main objective is to explore the associations between GDF-15 and the risk of CVD or all-cause mortality.<h4>Methods</h4>PubMed and ISI Web of Science (up to January 2018) electronic databases were browsed for eligible studies. The studies provided relevant data depicted as hazard rat ...[more]

PMID: 30697778

Similar Datasets

Project description:ContextPrevious meta-analyses evaluating the association between nut consumption and the risk of cardiovascular disease (CVD) had substantial methodological limitations and lacked recently published large prospective studies; hence, making an updated meta-analysis highly desirable.ObjectiveTo update the clinical guidelines for nutrition therapy in relation to the European Association for the Study of Diabetes (EASD), a systematic review and meta-analysis of prospective studies was conducted using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system to summarize the evidence of the association between total nuts, specific types of nuts, and the incidence of, and mortality from, CVD outcomes.Data sourcesRelevant articles were identified by searching the PubMed and Cochrane databases.Data extractionTwo independent researchers screened the articles to identify those that met the inclusion criteria.Data analysisThe inverse variance method with fixed-effect or random-effects models was used to pool data across studies (expressed as risk ratio [RR] and 95% confidence interval [CI]). Heterogeneity was tested and quantified using the Cochrane Q test and I2-statistic, respectively. The GRADE system was used to assess the quality of the evidence.ResultsNineteen studies were included in the analyses. The results revealed an inverse association between total nut consumption (comparing highest vs lowest categories) and CVD incidence (RR, 0.85; 95%CI, 0.800.91; I2,?0%), CVD mortality (RR, 0.77; 95%CI, 0.72-0.82; I2,?3%), coronary heart disease (CHD) incidence (RR, 0.82; 95%CI, 0.69-0.96; I2,?74%), CHD mortality (RR, 0.76; 95%CI, 0.67-0.86; I2,?46%), stroke mortality (RR, 0.83; 95%CI, 0.75-0.93; I2,?0%), and atrial fibrillation (RR, 0.85; 95%CI, 0.73-0.99; I2,?0%). No association was observed with stroke incidence and heart failure. The certainty of the evidence ranged from moderate to very low.ConclusionsThis systematic review and meta-analysis revealed a beneficial role of nut consumption in reducing the incidence of, and mortality from, different CVD outcomes.

Project description:OBJECTIVE: To quantify the dose-response relation between consumption of whole grain and specific types of grains and the risk of cardiovascular disease, total cancer, and all cause and cause specific mortality. DATA SOURCES: PubMed and Embase searched up to 3 April 2016. STUDY SELECTION: Prospective studies reporting adjusted relative risk estimates for the association between intake of whole grains or specific types of grains and cardiovascular disease, total cancer, all cause or cause specific mortality. DATA SYNTHESIS: Summary relative risks and 95% confidence intervals calculated with a random effects model. RESULTS: 45 studies (64 publications) were included. The summary relative risks per 90 g/day increase in whole grain intake (90 g is equivalent to three servings-for example, two slices of bread and one bowl of cereal or one and a half pieces of pita bread made from whole grains) was 0.81 (95% confidence interval 0.75 to 0.87; I(2)=9%, n=7 studies) for coronary heart disease, 0.88 (0.75 to 1.03; I(2)=56%, n=6) for stroke, and 0.78 (0.73 to 0.85; I(2)=40%, n=10) for cardiovascular disease, with similar results when studies were stratified by whether the outcome was incidence or mortality. The relative risks for morality were 0.85 (0.80 to 0.91; I(2)=37%, n=6) for total cancer, 0.83 (0.77 to 0.90; I(2)=83%, n=11) for all causes, 0.78 (0.70 to 0.87; I(2)=0%, n=4) for respiratory disease, 0.49 (0.23 to 1.05; I(2)=85%, n=4) for diabetes, 0.74 (0.56 to 0.96; I(2)=0%, n=3) for infectious diseases, 1.15 (0.66 to 2.02; I(2)=79%, n=2) for diseases of the nervous system disease, and 0.78 (0.75 to 0.82; I(2)=0%, n=5) for all non-cardiovascular, non-cancer causes. Reductions in risk were observed up to an intake of 210-225 g/day (seven to seven and a half servings per day) for most of the outcomes. Intakes of specific types of whole grains including whole grain bread, whole grain breakfast cereals, and added bran, as well as total bread and total breakfast cereals were also associated with reduced risks of cardiovascular disease and/or all cause mortality, but there was little evidence of an association with refined grains, white rice, total rice, or total grains. CONCLUSIONS: This meta-analysis provides further evidence that whole grain intake is associated with a reduced risk of coronary heart disease, cardiovascular disease, and total cancer, and mortality from all causes, respiratory diseases, infectious diseases, diabetes, and all non-cardiovascular, non-cancer causes. These findings support dietary guidelines that recommend increased intake of whole grain to reduce the risk of chronic diseases and premature mortality.

Dataset Information

Growth differentiation factor-15 and the risk of cardiovascular diseases and all-cause mortality: A meta-analysis of prospective studies.

Background and aim

Methods

Results

Conclusions

Publications

Growth differentiation factor-15 and the risk of cardiovascular diseases and all-cause mortality: A meta-analysis of prospective studies.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure